Anti-viral pill lacks EUA, SRP can't be issued yet: DOH
Molnupiravir (Photo courtesy of Merck & Co.) MANILA - The yet-to-be-approved anti-viral pill molnupiravir still lacks emergency use authorization and no suggested retail price can be issued since it is still under study by regulators, a health official said Friday. In an online media forum, Department of Health (DOH) Undersecretary Maria Rosario Vergeire noted that only four hospitals had been granted compassionate special permit (CSP)to administer the pill that is deemed to cut the risk of ...
Aurobindo Pharma Meneleo Hernandez Monaliza Balnig Salian Maria Rosario Vergeire Department Of Health Merck Co
Source: philippinetimes.com